Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study
Sign Up to like & getrecommendations! Published in 2022 at "Gut and Liver"
DOI: 10.5009/gnl220050
Abstract: Background/Aims Tegoprazan, a novel potassium-competitive acid blocker, is expected to overcome the limitations of proton pump inhibitors and effectively control nocturnal acid breakthrough. To evaluate the pharmacodynamics of tegoprazan versus dexlansoprazole regarding nocturnal acid breakthrough… read more here.
Keywords: nocturnal acid; regarding nocturnal; acid; dexlansoprazole regarding ... See more keywords
Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Neurogastroenterology and Motility"
DOI: 10.5056/jnm17037
Abstract: Received: March 14, 2017 Revised: None Accepted: March 14, 2017 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution,… read more here.
Keywords: medicine; long acting; nocturnal acid; acid breakthrough ... See more keywords